Precision Medicine Software Genedata Profiler™ Launched at Bio-IT World
News Apr 24, 2015
Genedata has announced at Bio-IT World Conference & Expo '15 the launch of Genedata Profiler™, an open, interoperable enterprise software platform designed to facilitate efficient patient and compound profiling processes.
Efficient profiling processes are a crucial element of successful precision medicine approaches in (bio-) pharmaceutical R&D. One particular strength of Genedata Profiler is that it supports the integrative analysis of NGS and other omics data with clinical patient data, ensuring the highest data security and quality standards.
The US National Institutes of Health defines precision medicine as "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." Genedata Profiler was developed in collaboration with leading pharmaceutical companies to process, manage and analyze very large data sets that include this genomic and phenotypic information. It delivers insight for pharmaceutical R&D to improve preclinical and clinical studies.
In particular, Genedata Profiler manages and federates all omics and related data from clinical samples while maintaining full patient privacy and chain of custody. Working with disease and genomic information from different studies, it allows innovative integrative data analyses. The software enables easy data, method and result sharing, promoting interdisciplinary collaboration between research teams both within and outside the organization.
Dr. Othmar Pfannes, CEO of Genedata, commented, "Today's launch of Genedata Profiler is another milestone in our strategy to deliver innovative solutions for efficient drug discovery and development processes. We believe successful precision medicine and translational research requires great efficiency in working with data from human samples in research environments. Interdisciplinary teams working on and distributing data must be able to collaborate easily, and should also be able to integrate disease and genomic information from external studies into their analyses. Our experience and domain knowledge, coupled with our collaborative approach with leading pharmaceutical companies worldwide, allow Genedata to provide solutions to all of these challenges in one complete software package."
Genedata Profiler is available immediately for annual licensing. The software will be demonstrated at Booth 232 in the Bio-IT World Expo in Seaport World Trade Center in Boston, April 21-23, 2015.
Computer scientists at Carnegie Mellon University say neural networks and supervised machine learning techniques can efficiently characterize cells that have been studied using single cell RNA-sequencing (scRNA-seq). This finding could help researchers identify new cell subtypes and differentiate between healthy and diseased cells.